Related Experiment Video
Updated: Feb 12, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1
Pedro Nicolau-Neto1, Antonio Palumbo2, Marco De Martino3
1Programa de Carcinogênese Molecular, Instituto Nacional de Câncer-INCA, Rua Andre Cavalcanti 37, Rio de Janeiro 20231-050, RJ, Brazil. pedronicolau.n@gmail.com.
Abstract:
FOXM1 (forkhead box protein M1) is a transcription factor that participates in all stages of tumor development, mainly through the control of cell cycle and proliferation, regulating the expression of genes involved in G1/S and G2/M transition and M phase progression. The ubiquitin conjugating enzyme E2 (UBE2C) is a member of the anaphase promoting complex/cyclosome, promoting the degradation of several target proteins along cell cycle progression, during metaphase/anaphase transition. FOXM1 and UBE2C have been found overexpressed in a wide range of different solid tumors. Therefore, the aim of this study was to investigate whether UBE2C is a transcriptional target of FOXM1, using esophageal squamous cell carcinoma (ESCC) as a model, in addition to several cancer-deposited data. Our results show that FOXM1 and UBE2C expression present a positive correlation in normal tissues and in 25 distinct tumor types, including ESCC, where these genes are overexpressed. Moreover, FOXM1 binds to UBE2C promoter region in ESCC cell line and transcriptionally activates it, leading to UBE2C upregulation. In conclusion, this study provides evidences that FOXM1 transcriptionally regulates UBE2C expression in ESCC and their deregulation may be a general phenomenon in human neoplasias.
Insights
Forkhead box protein M1 (FOXM1) transcriptionally activates the UBE2C gene, which is overexpressed in many cancers. This FOXM1-UBE2C pathway deregulation is a common event in human neoplasias.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- FOXM1 is a key transcription factor regulating cell cycle and proliferation in tumor development.
- UBE2C, involved in cell cycle progression, is overexpressed in various solid tumors.
- Both FOXM1 and UBE2C are frequently overexpressed in human cancers.
Purpose of the Study:
- To determine if UBE2C is a transcriptional target of FOXM1.
- To investigate the FOXM1-UBE2C regulatory relationship in esophageal squamous cell carcinoma (ESCC) and other cancers.
Main Methods:
- Correlation analysis of FOXM1 and UBE2C expression in normal and tumor tissues.
- Chromatin immunoprecipitation (ChIP) assay to assess FOXM1 binding to the UBE2C promoter.
- Analysis of gene expression data from multiple cancer types.
Main Results:
- A positive correlation between FOXM1 and UBE2C expression was observed in normal tissues and 25 tumor types, including ESCC.
- FOXM1 was found to bind to the UBE2C promoter region in an ESCC cell line.
- FOXM1 transcriptionally activates UBE2C, leading to its upregulation.
Conclusions:
- FOXM1 directly regulates UBE2C expression at the transcriptional level in ESCC.
- The observed deregulation of FOXM1 and UBE2C is a widespread phenomenon in human neoplasias.
- This regulatory axis represents a potential target for cancer therapy.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Transcriptional Regulation: Riboswitches
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...

